Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2

LCB1 is a computationally designed 56-mer miniprotein targeting the spike (S) receptor-binding motif of SARS-CoV- 2 with high potent activity (Science, 2020; Cell host microbe, 2021); however, recent studies have demonstrated that emerging SARS-CoV-2 variants are highly resistant to LCB1's inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanmei, Li, Min, Liu, Nian, Wu, Tong, Han, Xuelian, Zhao, Guangyu, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851916/
https://www.ncbi.nlm.nih.gov/pubmed/36682464
http://dx.doi.org/10.1016/j.antiviral.2023.105541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851916/
https://www.ncbi.nlm.nih.gov/pubmed/36682464
http://dx.doi.org/10.1016/j.antiviral.2023.105541

Ejemplares similares